This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
MetLife (MET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lemonade (LMND) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Lemonade (LMND) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lemonade (LMND) Expands in France With Homeowners Insurance
by Zacks Equity Research
Lemonade (LMND) revolutionizes insurance in France with its AI-powered homeowners coverage, backed by a strategic partnership with BNP Paribas Cardif.
Lemonade (LMND) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Lemonade (LMND) closed at $16.13, marking a -1.41% move from the previous day.
Lemonade (LMND) Stock Moves -0.55%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Lemonade (LMND) closed at $16.24, indicating a -0.55% shift from the previous trading day.
Lemonade (LMND) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
Lemonade (LMND) Q4 Earnings Top Estimates on Higher Premiums
by Zacks Equity Research
Lemonade (LMND) quarterly results reflect improved gross earned premiums, driven by an increase in in-force premium earned and lower expense.
Lemonade (LMND) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Lemonade (LMND) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Lemonade (LMND) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 22.78% and 2.13%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Lemonade (LMND) Outpaced the Stock Market Today
by Zacks Equity Research
In the latest trading session, Lemonade (LMND) closed at $17.90, marking a +1.19% move from the previous day.
Lemonade (LMND) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of Lemonade (LMND) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Lemonade (LMND) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Lemonade (LMND) reachead $17.67 at the closing of the latest trading day, reflecting a -1.89% change compared to its last close.
Lemonade (LMND) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Lemonade (LMND) reachead $16.05 at the closing of the latest trading day, reflecting a -0.8% change compared to its last close.
Lemonade (LMND) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
Lemonade (LMND) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
Lemonade (LMND) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Lemonade (LMND) closed at $17.18, marking a -0.17% move from the previous day.
Lemonade (LMND) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
The latest trading day saw Lemonade (LMND) settling at $17.48, representing a +0.98% change from its previous close.
Lemonade (LMND) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Lemonade (LMND) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Compared to Estimates, Lemonade (LMND) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Lemonade (LMND) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Lemonade (LMND) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 5.38% and 9.93%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Stock Moves -1.17%: What You Should Know
by Zacks Equity Research
Lemonade (LMND) concluded the recent trading session at $11.02, signifying a -1.17% move from its prior day's close.
Lemonade (LMND) Stock Moves -1.26%: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed the most recent trading day at $11.72, moving -1.26% from the previous trading session.
Here's Why MGIC Investment (MTG) Stock is an Attractive Bet
by Zacks Equity Research
MGIC Investment (MTG) stands to gain from higher insurance in force, a decline in loss and claims payments, better housing market fundamentals and prudent capital deployment.
Lemonade (LMND) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
Lemonade (LMND) closed the most recent trading day at $12.31, moving -1.68% from the previous trading session.
Should You Buy Lemonade (LMND) Stock for Better Returns Now?
by Zacks Equity Research
Lemonade (LMND) stands to gain from an improvement in continued shift in the mix of underlying products toward higher value policies and installment fees as well as a robust capital position.